| For: | Catalano M, Mini E, Nobili S, Vascotto IA, Ravizza D, Amorosi A, Tonelli F, Roviello F, Roviello G, Nesi G. Ulcerative colitis and colorectal cancer: Pathogenic insights and precision strategies for prevention and treatment. World J Gastrointest Oncol 2025; 17(10): 108514 [PMID: 41114102 DOI: 10.4251/wjgo.v17.i10.108514] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5190/full/v17/i10/108514.htm |
| Number | Citing Articles |
| 1 |
Yang Yang, Yifei Wang, Shuxin Zhang, Guangyao Chen, Shuangshuang Ji, Xincheng Wang, Sheng Li. Research hotspots, context, and future directions of ulcerative colitis comorbid with depression from 2006 to 2025: a bibliometric and visualization analysis. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1868648
|
| 2 |
Haiyan Lu, Xiangdang Hu, Yan Chen, Jie He. Colorectal cancer in ulcerative colitis: unraveling mechanisms and advancing surveillance and chemoprevention. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1793470
|
| 3 |
Yanmin Wu, Yan Li, Xufeng Yao, Yiyang Pan, Linlin Chen, Jian Zhang, Boyu Luo, Yue Teng, Mingqing Zhang, Chunwan Lu. 5-FU chemotherapy induces functional CD7+ and IL7R+ CTLs infiltration to suppress colorectal tumor progression. Science China Life Sciences 2026; doi: 10.1007/s11427-026-3437-0
|
| 4 |
Xuanchi Dong, Ji Yang, Langyu He, Huan Fang, Lei Wang, Jingjing Zhu, Jie Xu, Kedong Song, Zhiqiang Xuan. The Barrier–Microbiota–Inflammation Axis in Colorectal Cancer: Mechanisms and Emerging Diagnostic & Therapeutic Strategies. Cancers 2026; 18(4) doi: 10.3390/cancers18040576
|